PHTS Telemedizin Provides Telemedicine Solutions

SHL Telemedicine LtdSHL Telemedicine Ltd. (SWX:SHLTN), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that its wholly owned German subsidiary PHTS Telemedizin is part of an integrated care services contract in the state of Schleswig-Holstein whereby family doctors, physicians and hospitals in Schleswig-Holstein will refer patients of public health insurance companies IKK Nord and IKK-Direkt suffering from chronic heart illnesses to PHTS Telemedizin for the reception of telemedicine services.

PHTS Telemedizin (www.phts.de), through its monitoring centre based in Dusseldorf, will provide these patients suffering from chronic heart illnesses improved care around the clock.

Some of the PHTS Telemedizin (www.phts.de) partners in this integrated care solution are: IKK Nord, IKK-Direkt, Deutscher Hausärzteverband, Landesverband Schleswig-Holstein, Ärztegenossenschaft Schleswig-Holstein eG, 4K-Verbund der Kliniken Medizinisches Zentrum Klinikum Itzehoe, Westküstenkliniken Heide und Brunsbüttel gGmbH, FEK Friedrich-Ebert-Krankenhaus Neumünster GmbH, Universitätsklinikum Schleswig- Holstein Kiel and Universitätsklinikum Schleswig-Holstein Lubeck.

Eyal Lewin, Managing Director of PHTS Telemedizin (www.phts.de), comments: "Schleswig-Holstein's vast territory is well suited for the application of cardiac telemedicine solutions and I am confident in our ability to improve the quality of care for the chronically ill."

Erez Alroy, Co-CEO of SHL Telemedicine, adds: "We are very pleased with the development in the German market. The cooperation with the health community in Schleswig-Holstein emphasizes PHTS Telemedizin's leading position in the German telemedicine market and its continuing growth and progress. The goal of this contract is to improve the quality of care and quality of life for chronically ill heart patients and at the same time achieve better cost-efficiency."

About SHL TeleMedicine
SHL TeleMedicine Ltd. is a leading provider and developer of advanced personal telemedicine solutions to individuals and to the healthcare community. As a provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in the US, Europe and Israel. SHL is listed on the SWX Swiss Exchange, symbol SHLTN. For more information see www.shl-telemedicine.com.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...